Nuvalent, Inc. (NUVL) closed the last trading session at $103.93, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $142.65 indicates a 37.3% upside potential.The mean estimate comprises 17 short-term price targets with a standard deviation of $13.19. While the lowest estimate of $125.00 indicates a 20.3% increase from the current price level, the most optimistic analyst ...

Shares of LendingClub (LC) have gained 1.7% over the past four weeks to close the last trading session at $16.72, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.3 indicates a potential upside of 39.4%.The mean estimate comprises 10 short-term price targets with a standard deviation of $1.95. While the lowest estimate of $20.00 indicates a 19.6% increase from the current pri ...

Shares of Palomar (PLMR) have gained 1.7% over the past four weeks to close the last trading session at $121.68, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $165.67 indicates a potential upside of 36.2%.The average comprises six short-term price targets ranging from a low of $151.00 to a high of $183.00, with a standard deviation of $11.96. While the lowest estimate indicate ...

分组1 - Avita Medical Inc. (RCEL) shares have increased by 17.9% over the past four weeks, closing at $5.39, with a mean price target of $7 indicating a potential upside of 29.9% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $3.03, where the lowest estimate is $3.50 (a 35.1% decline) and the highest is $10.00 (an 85.5% increase) [2] - Analysts show strong agreement on RCEL's ability to report better earnings than previously predicted, which supports the view of potential upside [4] 分组2 - The Zacks Consensus Estimate for RCEL's current year earnings has increased by 12.2% over the last 30 days, with one estimate moving higher and no negative revisions [12] - RCEL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, the implied direction of price movement appears to be a useful guide [14]

Shares of West Pharmaceutical Services (WST) have gained 1.9% over the past four weeks to close the last trading session at $241.12, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $319.07 indicates a potential upside of 32.3%.The average comprises 14 short-term price targets ranging from a low of $265.00 to a high of $375.00, with a standard deviation of $28.52. While the lowes ...

Shares of Broadcom Inc. (AVGO) have gained 3.9% over the past four weeks to close the last trading session at $332.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $450.16 indicates a potential upside of 35.3%.The average comprises 39 short-term price targets ranging from a low of $335.00 to a high of $535.00, with a standard deviation of $45.71. While the lowest estimate ind ...

Core Viewpoint - Brookdale Senior Living (BKD) has shown a significant price increase of 17.4% over the past four weeks, with analysts projecting a mean price target of $19, indicating a potential upside of 27.1% from the current price of $14.95 [1] Price Targets and Analyst Consensus - The average price target for BKD ranges from a low of $17.00 to a high of $23.00, with a standard deviation of $2.71, suggesting a relatively tight clustering of estimates [2] - The lowest estimate indicates a 13.7% increase, while the highest suggests a 53.9% upside, highlighting the variability in analyst predictions [2] Earnings Estimates and Analyst Optimism - Analysts have shown strong agreement in revising earnings per share (EPS) estimates higher, which is a positive indicator for potential stock upside [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 16.3%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Potential - BKD currently holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Caution on Price Targets - While price targets are a common tool for investors, they should be approached with skepticism as they may not reliably indicate actual stock price movements [7][10]

💡 CoinMarketCap | Crypto Prediction Markets 💡The timeline sets the narrative → Liquidity sets the odds.You scroll the timeline to spot the next narrative.But to see if the market truly believes it, you follow the money.The Crypto Prediction Markets page tracks real-time probabilities backed by actual capital at stake:🔹 Price targets: Will BTC reach $100K?🔹 Market events: ETF decisions, upgrades, major launches🔹 True positioning: See where capital is flowingFind the Crypto odds here: https://t.co/nu0QAArJqk ...

Core Viewpoint - Merit Medical (MMSI) shows potential for significant upside, with a mean price target of $104.27 indicating a 26.8% increase from its current price of $82.22 [1] Price Targets and Estimates - The mean estimate consists of 11 short-term price targets with a standard deviation of $9.12, suggesting variability among analysts [2] - The lowest estimate is $90.00, indicating a 9.5% increase, while the highest estimate is $122.00, suggesting a potential surge of 48.4% [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts exhibit growing optimism about MMSI's earnings prospects, as indicated by upward revisions in EPS estimates [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.2%, with two estimates moving higher and no negative revisions [12] - MMSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Masimo (MASI) has shown a 7.2% increase in stock price over the past four weeks, with a mean price target of $183.75 indicating a potential upside of 31.1% from the current price of $140.2 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $16.06, where the lowest estimate is $162.00 (15.6% increase) and the highest is $210.00 (49.8% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about MASI's earnings prospects, with a positive trend in earnings estimate revisions indicating potential upside [4][11] - Over the last 30 days, two earnings estimates have been revised higher, leading to a 0.3% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - MASI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the magnitude of MASI's potential gains, it does provide a useful guide for the direction of price movement [14]